相关实验视频

Updated: Jun 21, 2026

A Western Blotting Protocol for Small Numbers of Hematopoietic Stem Cells
08:45

A Western Blotting Protocol for Small Numbers of Hematopoietic Stem Cells

Published on: August 22, 2018

10.4K

聚焦儿科免疫血小板缺血症中的eltrombopag度:中国的一项单中心观察性研究

Shuyue Dong1, Zhifa Wang1, Nan Wang2

  • 1Hematology Oncology Center Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China.

Pediatric investigation
|March 22, 2024
PubMed
概括

在儿科免疫血小板缺血症 (ITP) 中,Eltrombopag的度有所不同. 较高的eltrombopag水平与不良药物反应相关,这表明个性化剂量对于有效的ITP管理至关重要.

关键词:
专注 集中 集中 集中有效性 有效性.这是Eltrombopag.免疫性血小板减少症.儿科 儿科 儿科安全的安全的安全的安全的安全.

更多相关视频

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.4K
Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

988

相关概念视频

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...